Bank of America
RVPH

Bank of America’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bank of America’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46
Closed -$256 – 6680
2025
Q4 		$256 Buy
46
+19
+70% +$211 ﹤0.01% 6660
2025
Q3 		$198 Buy
27
+5
+23% +$42 ﹤0.01% 7733
2025
Q2 		$166 Buy
22
+4
+22% +$62 ﹤0.01% 7876
2025
Q1 		$335 Buy
18
+2
+13% +$63 ﹤0.01% 7592
2024
Q4 		$581 Buy
16
+5
+45% +$139 ﹤0.01% 7385
2024
Q3 		$310 Sell
11
-186
-94% -$4.13K ﹤0.01% 7479
2024
Q2 		$5.05K Sell
197
-899
-82% -$40.9K ﹤0.01% 7002
2024
Q1 		$82.9K Buy
1,096
+347
+46% +$27.5K ﹤0.01% 6328
2023
Q4 		$77.2K Buy
+749
New +$67.2K ﹤0.01% 6479
2023
Q3 		– Sell
-10
Closed -$932 – 7664
2023
Q2 		$1.13K Buy
+10
New +$1.27K ﹤0.01% 7226
2023
Q1 		– Sell
-2
Closed -$175 – 7687
2022
Q4 		$144 Buy
+2
New +$153 ﹤0.01% 7611
2022
Q3 		– Hold
0
– – – 8142
2022
Q2 		– Hold
0
– – – 8323
2022
Q1 		– Hold
0
– – – 8685
2021
Q4 		– Sell
-1,240
Closed -$88.4K – 8582
2021
Q3 		$101K Buy
+1,240
New +$97.9K ﹤0.01% 6720
2020
Q2 		– Sell
-16,550
Closed -$3.48M – 7090
2020
Q1 		$3.48M Hold
16,550
– – ﹤0.01% 3020
2019
Q4 		$3.47M Hold
16,550
– – ﹤0.01% 3569
2019
Q3 		$3.43M Hold
16,550
– – ﹤0.01% 3571
2019
Q2 		$3.38M Buy
+16,550
New +$3.37M ﹤0.01% 3594

Other funds holding RVPH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Bank of America's RVPH Position: Q1 2026 in Review

Bank of America sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 46 shares — an estimated $256 sold.

Bank of America first reported a position in RVPH in Q2 2019 and held it in 16 quarters. The position peaked at $3.48M in Q1 2020. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Bank of America reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 46 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $256.
  • Bank of America first reported a position in REVIVA PHARMA HLDGS INC in Q2 2019 and held it in 16 quarters.
  • Bank of America's REVIVA PHARMA HLDGS INC position peaked at $3.48M in Q1 2020.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.